Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7960384
Dipeptidyl peptidase inhibitors
granted patentUS 7960383
Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors
granted patentUS 7956220
MAO-B inhibitors useful for treating obesity
granted patentUS 7951831
Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhi
granted patentUS 7951820
Triazole compounds useful as protein kinase inhibitors
granted patentUS 7951809
Inhibitors of p38
granted patentUS 7951770
Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated
granted patentUS 7943659
MAPK/ERK kinase inhibitors
granted patentUS 7943626
Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxam
granted patentUS 7943593
Compositions comprising inhibitors of IMPDH enzyme
granted patentUS 7935693
Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles usef
granted patentUS 7928129
Nanomolar Ξ²-lactamase inhibitors
granted patentUS 7919621
Tricyclic inhibitors of 5-lipoxygenase
granted patentUS 7919523
Inhibitors of aspartyl protease
granted patentUS 7919520
Inhibitors of tace
granted patentUS 7919513
Inhibitors of p38
granted patentUS 7915305
Thiophene-carboxamides useful as inhibitors of protein kinases
granted patentUS 7910587
Quinoxalinyl dipeptide hepatitis C virus inhibitors
granted patentUS 7906650
Caspase inhibitors and uses thereof
granted patentUS 7906550
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted patentUS 7906530
1,7-naphthyridine derivatives as p38 MAP kinase inhibitors
granted patentUS 7906523
Dipeptidyl peptidase inhibitors
granted patentUS 7906513
Hydrazide-containing hepatitis C serine protease inhibitors
granted patentUS 7902239
Diaminotriazoles useful as inhibitors of protein kinases
granted